ICON PLC Share Price Irish S.E.
Equities
ICLR
IE0005711209
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
297.8 EUR | +1,385.29% | -8.66% | 0.00% |
05-16 | Diamyd Medical AB Appoints ICON plc to Conduct Interim Analysis for the Phase 3 Trial | CI |
04-30 | ICON Prices $2 Billion Debt Offering | MT |
Sales 2024 * | 8.64B 7.96B 677B | Sales 2025 * | 9.28B 8.55B 727B | Capitalization | 26.52B 24.43B 2,077B |
---|---|---|---|---|---|
Net income 2024 * | 820M 755M 64.22B | Net income 2025 * | 1B 921M 78.32B | EV / Sales 2024 * | 3.33 x |
Net Debt 2024 * | 2.29B 2.11B 179B | Net Debt 2025 * | 1.13B 1.04B 88.5B | EV / Sales 2025 * | 2.98 x |
P/E ratio 2024 * |
32.4
x | P/E ratio 2025 * |
26.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.35% |
Latest transcript on ICON PLC
Managers | Title | Age | Since |
---|---|---|---|
Stephen Cutler
CEO | Chief Executive Officer | 63 | 31/10/11 |
Brendan Brennan
DFI | Director of Finance/CFO | 45 | 31/12/05 |
Ciaran Murray
CHM | Chairman | 61 | 02/10/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Climax
FOU | Founder | 71 | 31/05/90 |
Stephen Cutler
CEO | Chief Executive Officer | 63 | 31/10/11 |
Linda Grais
BRD | Director/Board Member | 68 | 30/06/21 |
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.98% | 40.65B | |
-10.87% | 27.12B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B | |
-8.12% | 11.19B |
- Stock Market
- Equities
- ICLR Stock
- ICLR Stock